Overview

Role of Nefopam in Rituximab Transfusion Reaction

Status:
Not yet recruiting

Trial end date:
2023-11-20

Target enrollment:

Participant gender:

Summary

the patients will be taken nefopam ampule 50 mg before rituximab in the first group while the second group will be taken diphenhydramine ampule 10 mg before rituximab in the second group

Phase:

Phase 3

Details

Lead Sponsor:

Ministry Of Health / Nineveh Health Directorate

Treatments:

Diphenhydramine
Nefopam
Promethazine